Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02131129 · ClinicalTrials.gov registry record · NA
rTMS in First Episode Psychosis
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT02131129 is a NA study that has completed, run by Indiana University. The registered enrollment target is 20 participants.
The verdict
NCT02131129, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study proposes to examine the application of rTMS for the treatment of cognitive dysfunction in FEP. This is an important population for study because if effective, rTMS may represent a preventative treatment for the development of social and vocational impairment that is associated with cognitive dysfunction in schizophrenia. This study will also seek to refine the understanding of the brain circuitry that mediates the potential pro-cognitive effects of rTMS through the use of functional magnetic resonance imaging (fMRI) at baseline and following the course of rTMS administration.
Interventions
- DEVICE Sham Comparator
- DEVICE rTMS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2014-04-30 |
| Est. Completion | 2016-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02131129
The ClinicalTrials.gov registry entry for NCT02131129 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham Comparator is the first listed.
NCT02131129 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02131129 about?
NCT02131129 is a clinical study titled "rTMS in First Episode Psychosis". This study proposes to examine the application of rTMS for the treatment of cognitive dysfunction in FEP. This is an important population for study because if effective, rTMS may represent a preventative treatment for the development of social and vocational impairment that is associated with cognit...
What is the current status of trial NCT02131129?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2014-04-30. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02131129?
The interventions under investigation include: Sham Comparator (DEVICE), rTMS (DEVICE).
Who is sponsoring clinical trial NCT02131129?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.